Renal effects of glucagon-like peptide receptor agonists in patients with type 1 diabetes mellitus

Renal effects of glucagon-like peptide receptor agonists in patients with type 1 diabetes mellitus

The purpose of our study is to assess the effects of glucagon-like peptide-1 receptor agonists (GLP-1R agonists) on early markers of kidney damage in patients with type 1 diabetes mellitus (DM). Materials and methods. The study included 27 patients with type 1 diabetes with normo- (n=16) and microal...

Full description

Bibliographic Details
Main Authors: O K Vikulova, Z T Zuraeva, O V Michaleva, L V Nikankina, M Sh Shamkhalova, M V Shestakova, I I Dedov
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2018-06-01
Series:Терапевтический архив
Subjects:
type 1 diabetes mellitus
diabetic kidney disease
nephroprotective therapy
incretins
glucagon-like peptide type 1 receptor agonists
Online Access:https://ter-arkhiv.ru/0040-3660/article/viewFile/32775/pdf

Internet

https://ter-arkhiv.ru/0040-3660/article/viewFile/32775/pdf

Similar Items